i don't even own the stock anymore and I'm the 1st to post this?  By the way i am amazed by the number of you who are still hanging on to this thing.  The product (pennsaid) doesn't sell period.  They have a partner who doesn't even want to be in the drug game and to this point has done nothing to promote the product.  Pennsaid 2 is unlikely to have any better penetration.  If you look through the annals of the stock market you won't find too many turnaround stories that Nuvo is required to undertake in order to be deemed a successful company.  Current Management has been no better than Beckie.

http://www.cbc.ca/news/health/story/2013/02/12/nsaid-diclofenac.html